Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
RemeGen
Pharma
Congress's biotech report, NIH ban, GSK-ABL—Fierce Pharma Asia
A congressional committee released a report on the U.S.-China biotech rivalry. The NIH blocked China's access to some databases. And more.
Angus Liu
Apr 11, 2025 10:31am
Merck, AstraZeneca, Astellas—Fierce Pharma Asia
Feb 7, 2025 9:00am
Seagen undaunted by AstraZeneca-Daiichi's Enhertu
Oct 29, 2021 3:32pm
Seagen-RemeGen, AZ-Daiichi, Takeda and more—Fierce Pharma Asia
Aug 13, 2021 9:25am
Biogen-Eisai, COVID vaccine, RemeGen's ADC—Fierce Pharma Asia
Jun 11, 2021 9:25am
